Compound ID | 1445
Class: Antimicrobial peptide
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Active against Staphylococcus aureus and Gram-negatives such as E.coli |
| Institute where first reported: | Promore Pharma, SWE |
| Year first mentioned: | 2017 |
| Highest developmental phase: | Preclinical |
| External links: | |
| Citations: |
|